L & S Advisors’s Edwards Lifesciences EW Stock Holding History

L & S Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-37,752	Closed	-$2.19M	–	310
2018 Q3	$2.19M	Sell	37,752 -17,973	-32%	-$879K	0.28%	87
2018 Q2	$2.7M	Buy	55,725 +36,123	+184%	+$1.69M	0.46%	63
2018 Q1	$912K	Buy	+19,602	New	+$851K	0.17%	128
2016 Q4	–	Sell	-54,384	Closed	-$2.19M	–	173
2016 Q3	$2.19M	Sell	54,384 -4,722	-8%	-$178K	0.6%	54
2016 Q2	$1.97M	Sell	59,106 -1,509	-2%	-$51.6K	0.45%	56
2016 Q1	$1.78M	Sell	60,615 -106,341	-64%	-$2.93M	0.44%	51
2015 Q4	$4.39M	Sell	166,956 -5,688	-3%	-$148K	1.1%	34
2015 Q3	$4.09M	Buy	172,644 +85,824	+99%	+$2.07M	1.19%	29
2015 Q2	$2.06M	Buy	86,820 +246	+0.3%	+$5.55K	0.52%	66
2015 Q1	$2.06M	Buy	+86,574	New	+$1.94M	0.54%	69

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

L & S Advisors's EW Position: Q4 2018 in Review

L & S Advisors sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 37,752 shares — an estimated $2.19M sold.

L & S Advisors first reported a position in EW in Q1 2015 and held it in 10 quarters. The position peaked at $4.39M in Q4 2015. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

L & S Advisors reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
L & S Advisors sold 37,752 Edwards Lifesciences shares in Q4 2018, an estimated $2.19M.
L & S Advisors first reported a position in Edwards Lifesciences in Q1 2015 and held it in 10 quarters.
L & S Advisors's Edwards Lifesciences position peaked at $4.39M in Q4 2015.
875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on L & S Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.